Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvement.

[1]  R. Gilbert,et al.  Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: A systematic review with meta‐analysis , 2007, Head & neck.

[2]  L. Wilson,et al.  Postoperative Concurrent Chemoradiotherapy with Mitomycin in Advanced Squamous Cell Carcinoma of the Head and Neck: Results from Three Prospective Randomized Trials , 2006, Cancer journal.

[3]  M. van Glabbeke,et al.  Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) , 2005, Head & neck.

[4]  J. Jacobs,et al.  Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. , 2004, The New England journal of medicine.

[5]  Jacques Bernier,et al.  Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. , 2004, The New England journal of medicine.

[6]  J. Pignon,et al.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta analysis of chemotherapy on head and neck cancer , 2001 .

[7]  J. Bourhis,et al.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data , 2000, The Lancet.

[8]  G. Calais,et al.  Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. , 1999, Journal of the National Cancer Institute.

[9]  K. Ang,et al.  Precisely defining high‐risk operable head and neck tumors based on rtog #85‐03 and #88‐24: Targets for postoperative radiochemotherapy? , 1998, Head & neck.

[10]  B. Jeremic,et al.  Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  E. Cohen-Jonathan,et al.  Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. , 1996, International journal of radiation oncology, biology, physics.

[12]  J. Pignon,et al.  Meta-analysis of chemotherapy in head and neck cancer: individual patient data vs literature data. , 1995, British Journal of Cancer.

[13]  T. Pajak,et al.  Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.

[14]  H. Eckel,et al.  [Cisplatin/5-FU versus carboplatin/5-FU. 5 year follow-up]. , 1994, HNO.

[15]  Icru.  Prescribing, recording, and reporting photon beam therapy , 1993 .

[16]  A S Garden,et al.  Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. , 1993, International journal of radiation oncology, biology, physics.

[17]  S. Rockwell,et al.  Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials. , 1993, International journal of radiation oncology, biology, physics.

[18]  B. Qaqish,et al.  Simultaneous chemoradiation in the treatment of advanced head and neck cancer. , 1992, Archives of otolaryngology--head & neck surgery.

[19]  L. Peters,et al.  Resection of advanced cervical metastasis prior to definitive radiotherapy for primary squamous carcinomas of the upper aerodigestive tract , 1992, Head & neck.

[20]  R. Crooijmans,et al.  Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin: influence of treatment sequence. , 1991, International journal of radiation oncology, biology, physics.

[21]  J. Jacobs,et al.  Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03. , 1991, International journal of radiation oncology, biology, physics.

[22]  R. Crooijmans,et al.  Effectiveness of cis-platin and carboplatin in the chemotherapy of squamous cell carcinoma grown as multicellular spheroids. , 1990, Anticancer research.

[23]  S. Rockwell,et al.  Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. , 1989, International journal of radiation oncology, biology, physics.

[24]  D. Ettinger,et al.  Ifosfamide in the treatment of non-small cell lung cancer. , 1989, Seminars in oncology.

[25]  C. Coughlin,et al.  Biologic and clinical developments of cisplatin combined with radiation: concepts, utility, projections for new trials, and the emergence of carboplatin. , 1989, Seminars in oncology.

[26]  R. Gelber,et al.  Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. , 1987, Head & neck surgery.

[27]  E. Douple,et al.  Carboplatin as a potentiator of radiation therapy. , 1985, Cancer treatment reviews.

[28]  A. Hart,et al.  Prognostic factors of neck node metastasis. , 1982, Clinical otolaryngology and allied sciences.

[29]  H. Bartelink,et al.  Radiotherapy of lymph node metastases in patients with squamous cell carcinoma of the head and neck region. , 1982, International journal of radiation oncology, biology, physics.

[30]  L. Freedman.  Tables of the number of patients required in clinical trials using the logrank test. , 1982, Statistics in medicine.

[31]  N. Mantel.  Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[32]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[33]  D.,et al.  Regression Models and Life-Tables , 2022 .